COMMUNIQUÉS West-GlobeNewswire

Advantis Corp. Signs Lease, Triples Production Capacity

12/03/2018 - 14:15

NEWPORT BEACH, CA, March 12, 2018 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT) signed a new lease last week that will triple the square footage of its packing and canning facility, according to Advantis CEO [...]

Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock

12/03/2018 - 14:15

BURLINGAME, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS ), a clinical-stage biopharmaceutical company focused on the development and commercialization of small molecule and [...]

Transactions under Novozymes’ stock buyback program

12/03/2018 - 14:09

Please read the full announcement in the attached PDF 2018_07_Stock_Buybackprogram_EN

Aptevo Therapeutics Presents New Patient-Reported Data With IXINITY

12/03/2018 - 14:02

Data Presented at the Thrombosis and Hemostasis 2018 Summit of North America SEATTLE, March 12, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO ), a biotechnology company focused on developing novel [...]

Applications Now Open for the 2018 Medtronic Global Champions Team

12/03/2018 - 14:01

Medtronic Seeks Up to 20 Runners Who Benefit from Medical Technology Selected Runners Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October 2018 Applications Accepted at www. [...]

Arbutus Announces Conference Call to Provide a Corporate Update and Fourth Quarter 2017 Year-End Financial Results

12/03/2018 - 14:00

VANCOUVER, British Columbia and WARMINSTER, Pa., March 12, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today [...]

NewLink Genetics to Participate in Upcoming Investor Conferences

12/03/2018 - 14:00

AMES, Iowa, March 12, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) announced today that the company will participate in the following investor conferences: Oppenheimer 28 th Annual Healthcare [...]

Exalenz Announces Fourth Quarter and Full Year 2017 Financial Results

12/03/2018 - 14:00

- 2017 revenue increased 127% to $9.5 million, compared with $4.2 million in 2016 - - Fourth quarter 2017 revenue increased 161% compared with same period in 2016 - MODI’IN, Israel and MANASQUAN, N.J., March 12, 2018 ( [...]

Share buy-back week 10/2018

12/03/2018 - 13:58

Announcement 12 March 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]

Zosano Pharma Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Operational Update

12/03/2018 - 13:45

First patient enrolled in long term safety study in November 2017 Pivotal efficacy data for M207 published in October 2017 Allowed patent application to be issued in March 2018 extends proprietary position for M207 to [...]

Zecotek Introduces Innovative Wireless ASIC Microchip For Positron Emission Tomography Medical Imaging

12/03/2018 - 13:30

VANCOUVER, British Columbia, March 12, 2018 (GLOBE NEWSWIRE) -- Zecotek Photonics Inc. (“ Zecotek ” or the “ Company ”) (TSX-V: ZMS )(Frankfurt: W1I )(OTCPK:ZMSPF), a developer of leading-edge photonics technologies for [...]

Big Leap for LP MedTainer Orders; California Ramps Up

12/03/2018 - 13:30

CORONA, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMARKETS:ACOL) revealed today that Canadian licensed producers Aurora Cannabis Inc., OrganiGram and Tilray have posted March orders for more than 30,000 [...]

Portola Pharmaceuticals Appoints Biotech Legal Veteran John Moriarty as Executive Vice President and General Counsel

12/03/2018 - 13:30

SOUTH SAN FRANCISCO, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced the appointment of John B. Moriarty, J.D., as executive vice president and general counsel [...]

Cocrystal Pharma Announces Uplist to The Nasdaq Capital Market

12/03/2018 - 13:30

ATLANTA, GA and BOTHELL, WA, March 12, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral [...]

Scythian Biosciences Corp. Announces Letter of Intent to Acquire Argentina-Based ABP S.A.

12/03/2018 - 13:29

TORONTO, March 12, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) (OTC Pink:SCCYF) is pleased to announce that it has entered into a non-binding [...]

iKang Announces Receipt of Acquisition Proposal from Yunfeng Capital and Alibaba

12/03/2018 - 13:24

BEIJING, March 12, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), a major provider in China’s fast growing private preventive healthcare services market, today [...]

Immuron Commences US Non-Deal Institutional Investor Roadshow

12/03/2018 - 13:17

MELBOURNE, Australia, March 12, 2018 (GLOBE NEWSWIRE) -- Australian microbiome biopharmaceutical company Immuron Limited (ASX:IMC)(NASDQ:IMRN) is pleased to release to shareholders and investors its latest Company [...]

Saniona AB: Saniona's partner Cadent Therapeutics initiates Phase 1 trial for joint ataxia and tremor program

12/03/2018 - 13:16

PRESS RELEASE 12 March 2018 Saniona, a leading biotech company in the field of ion channels, today announced that its collaboration partner, Cadent Therapeutics, has initiated Phase 1 trial for CAD-1883 for the [...]

Novo Nordisk A/S: Share repurchase programme

12/03/2018 - 13:16

Bagsværd, Denmark, 12 March 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]